Johnson & Johnson - stock earnings

JNJ Upcoming estimated earnings

DateLow RevenueAverage RevenueHigh Revenue
Oct. 18, 2022, 8:30 a.m. 22.5 billion 23.5 billion 24.1 billion

JNJ Quarterly earnings

DateEarningsRevenue
2020Q3 3.6 billion USD 21.1 billion USD
2021Q1 1.7 billion USD 22.5 billion USD
2021Q2 6.2 billion USD 22.3 billion USD
2021Q3 6.3 billion USD 23.3 billion USD
2021Q4 3.7 billion USD 23.3 billion USD
2022Q1 4.7 billion USD 24.8 billion USD
2022Q2 5.1 billion USD 23.4 billion USD
2022Q3 4.8 billion USD 24.0 billion USD

JNJ Yearly earnings

DateEarningsRevenue
2017 1.3 billion USD 76.5 billion USD
2018 15.3 billion USD 81.6 billion USD
2019 15.1 billion USD 82.1 billion USD
2021 14.7 billion USD 82.6 billion USD
2022 20.9 billion USD 93.8 billion USD

JNJ

List: Champions

Price: 166.72USD

52 week range price:
155.72
186.69

Dividend Yield: 2.44%

5-year range yield:
1.79%
2.44%

Forward Dividend Yield: 2.71%

Payout Ratio: 43.46%

Payout Ratio Range:
40.69%
589.80%

Dividend Per Share: 4.52 USD

Earnings Per Share: 10.40 USD

P/E Ratio: 29.52

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers—General

Volume: 5.7 million

Ebitda: 2.9 billion

Market Capitalization: 440.0 billion

Average Dividend Frequency: 4

Years Paying Dividends: 61

DGR3: 5.78%

DGR5: 5.87%

DGR10: 6.42%

DGR20: 9.43%

Links: